Jeffrey Greve

Executive Vice President and Chief Financial Officer

Professional Overview
Jeffrey Greve is an accomplished finance executive with over 25 years of experience in the pharmaceutical industry. As the Executive Vice President and Chief Financial Officer at Sagent Pharmaceuticals, he is responsible for overseeing the company's global financial operations, strategic planning, and business development initiatives.

Experience Summary

Current Role
As the Chief Financial Officer at Sagent Pharmaceuticals, Jeffrey is instrumental in driving the company's financial strategy and performance. He is responsible for managing the company's financial reporting, budgeting, and internal controls, as well as leading key business initiatives that support Sagent's growth and profitability. Under his financial leadership, Sagent has achieved significant operational efficiencies and unlocked new revenue streams.

Career Progression
Prior to his current role, Jeffrey held various positions within Sagent Pharmaceuticals, including Vice President of Controller and Director of External and Technical Reporting. In these roles, he played a pivotal part in optimizing the company's financial processes, enhancing reporting capabilities, and supporting strategic decision-making. Before joining Sagent, Jeffrey was an Assurance Senior Manager at PricewaterhouseCoopers, where he gained extensive experience in public accounting and financial auditing.

Academic Background
Jeffrey holds a Bachelor of Business Administration (BBA) degree in Accountancy from the University of Notre Dame, where he graduated with distinction.

Areas of Expertise
Jeffrey's expertise spans a wide range of financial disciplines, including financial reporting, treasury management, budgeting, and internal controls. He is adept at driving operational excellence, implementing cost-saving initiatives, and spearheading strategic projects that contribute to the company's overall growth and profitability. Additionally, he possesses strong leadership and team-building skills, enabling him to effectively collaborate with cross-functional teams and drive organizational change.

Professional Impact
Under Jeffrey's financial stewardship, Sagent Pharmaceuticals has achieved significant milestones, including the successful integration of acquired businesses, the implementation of robust financial systems and processes, and the optimization of the company's global supply chain. His strategic insights and decision-making have been instrumental in positioning Sagent as a leading player in the pharmaceutical industry.

Conclusion
With his extensive experience, deep industry knowledge, and proven track record of financial leadership, Jeffrey Greve is a valuable asset to Sagent Pharmaceuticals. In his role as the Executive Vice President and Chief Financial Officer, he continues to drive the company's financial strategy and operational efficiency, positioning Sagent for continued success in the global pharmaceutical market.